BusinessNational Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer CommunityBy Nasdaq OMXMay 22, 2017, 1:13 PM UTC
BusinessNational Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer CommunityBy Nasdaq OMXMay 22, 2017, 1:13 PM UTC
BusinessNational Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer CommunityBy Nasdaq OMXMay 22, 2017, 1:13 PM UTC
BusinessNational Survey Shows Resource, Emotional and Support Needs of the Ovarian Cancer CommunityBy Nasdaq OMXMay 22, 2017, 1:13 PM UTC
BusinessTESARO Partners With Clinigen to Initiate European Managed Access Program for Niraparib in Patients With Recurrent Ovarian CancerBy Nasdaq OMXMay 11, 2017, 6:01 AM UTC
BusinessAvid Runner Creates 50+ Member Team to Support Ovarian Cancer After Battling the DiseaseBy Nasdaq OMXMay 5, 2017, 6:58 PM UTC
BusinessTESARO Announces Availability of Zejula™ (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S.By Nasdaq OMXApr 19, 2017, 8:16 PM UTC
BusinessTESARO Announces Availability of Zejula™ (Niraparib) for Patients With Recurrent Ovarian Cancer in the U.S.By Nasdaq OMXApr 19, 2017, 8:16 PM UTC
